We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
-7.59%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$120M
AUM Growth
-$23.7M
Cap. Flow
-$10.3M
Cap. Flow %
-8.56%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
LYEL icon
Lyell Immunopharma
LYEL
+$8.06M
2
ALMS
Alumis Inc
ALMS
+$1.95M

Top Sells

Rank Stock Value
1
HIMS icon
Hims & Hers Health
HIMS
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALMS
1
Alumis Inc
ALMS
$3.69B
$45.4M 37.79%
5,779,348
+194,459
+3% +$1.95M
HIMS icon
2
Hims & Hers Health
HIMS
$6.26B
$22.7M 18.91%
939,860
-819,454
-47% -$20.3M
CGON icon
3
CG Oncology
CGON
$6.44B
$19.9M 16.53%
692,550
– –
IRON icon
4
Disc Medicine
IRON
$3.03B
$19M 15.78%
299,069
– –
CGEM icon
5
Cullinan Oncology
CGEM
$1.08B
$8.01M 6.67%
657,905
– –
LYEL icon
6
Lyell Immunopharma
LYEL
$336M
$5.21M 4.33%
+406,652
New +$8.06M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q4 2024 Portfolio in Review

As of Q4 2024, Foresite Capital Management V held 6 positions worth $120M, down 16% from $144M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V withdrew a net $10.3M in Q4 2024, reducing 1 holding. Its largest reduction was Hims & Hers Health, cutting an estimated $20.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Management V opened a new position in Lyell Immunopharma worth $5.21M.

  • Foresite Capital Management V's largest Q4 2024 buy was Lyell Immunopharma: 406,652 shares worth $5.21M.
  • Foresite Capital Management V added most to Alumis Inc in Q4 2024, an estimated $1.95M increase.
  • Foresite Capital Management V's biggest Q4 2024 reduction was Hims & Hers Health, cutting an estimated $20.3M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $120M portfolio in Q4 2024.
  • Foresite Capital Management V opened 1 new position and closed 0 in Q4 2024.
  • Foresite Capital Management V's portfolio value fell 16% quarter-over-quarter to $120M.

Based on Foresite Capital Management V's 13F filing for Q4 2024, filed 14 Feb 2025.